Price $27.19 |
Market Cap
1.25B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.88
|
P/S
5.47
|
Dividend %
-
|
|
P/CF
97.8
|
P/FCF
-
|
Op. Cash Flow
-3.5K
|
FCF
-0.2
|
|
Op. Margin
-8.30%
|
Net Margin
-9.50%
|
ROE
-9.10%
|
ROI
-6.20%
|
|
ROA
-6.20%
|
EPS Growth
7.70%
|
Current Ratio
4.3
|
Debt/Equity
19.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $2.68 | - | - | 47.2M | Strong Buy |
| Premier Inc (PINC) | $37.82 | - | - | 4.91B | Strong Buy |
| US NeuroSurgical Holdings Inc (USNU) | $0.23 | - | - | 1.5M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.30 | - | - | 52.8M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.76 | - | - | 12.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
